September 24, 2025 a 03:32 am

ALB: Dividend Analysis - Albemarle Corporation

Company Logo

🗣️ Albemarle Corporation, a well-established firm, exhibits strong dividend stability, maintaining consistency over the past 32 years. The company offers a moderate yield of 2.13%, with a diligent growth approach. Despite current challenges in profitability, its long-term dividend reliability boosts investor confidence.

📊 Overview

Albemarle Corporation operates within the Chemicals sector and has admirably maintained steady dividends over an impressive span of 32 years, indicating robust dividend reliability and investor trust.

Metric Details
Sector Chemicals
Dividend Yield 2.13%
Current Dividend Per Share 2.65 USD
Dividend History 32 years
Last Cut or Suspension None

📈 Dividend History

Albemarle's dividend history stands out with 32 years of uninterrupted payments, which serves as a beacon of its stable financial management. Historical performance is a critical factor for income-focused investors.

Dividend History Chart
Year Dividend Per Share (USD)
2025 1.215
2024 1.610
2023 1.600
2022 1.580
2021 1.560

📈 Dividend Growth

The firm’s dividend growth over 3 and 5 years suggests a conservative but consistent appreciation, essential for long-term dividend growth strategies.

Time Growth
3 years 1.06%
5 years 1.84%

The average dividend growth is 1.84% over 5 years. This shows moderate but steady dividend growth.

Dividend Growth Chart

📉 Payout Ratio

Currently, Albemarle’s payout ratios are negative across EPS and FCF metrics, an indicator of potential operational reinvestments or temporary income challenges.

Key Figure Ratio
EPS-based -33.53%
Free cash flow-based -174.78%

While these negative figures indicate reinvestment efforts or income fluctuations, they necessitate close monitoring to assess future dividend sustainability.

✅ Cashflow & Capital Efficiency

Evaluating the determinants of free cash flow yield and operating cash ratio reveals insights into Albemarle's operational liquidity and reinvestment efficiency.

Year 2024 2023 2022
Free Cash Flow Yield -9.72% -4.86% 2.54%
Earnings Yield -11.66% 9.28% 10.59%
CAPEX to Operating Cash Flow 240.12% 162.17% 66.13%
Stock-based Compensation to Revenue 0.60% 0.38% 0.42%
Free Cash Flow / Operating Cash Flow Ratio -140.12% -62.02% 33.87%

Notable fluctuations in cash flow yield reflect operational investments; however, positive shifts in operating cash flow ratio illustrate improvements towards capital efficiency.

⚠️ Balance Sheet & Leverage Analysis

Debt assessment metrics such as debt-to-equity and net debt to EBITDA ratios are paramount in deciphering financial health and leverage capacity.

Year 2024 2023 2022
Debt-to-Equity 36.30% 45.48% 41.54%
Debt-to-Assets 21.77% 23.43% 21.46%
Debt-to-Capital 26.63% 31.26% 29.35%
Net Debt to EBITDA -2.40 4.28 0.64
Current Ratio 0 0 0
Quick Ratio 1.19 0.86 1.13

The leverage position indicates a controlled debt structure, though the net debt to EBITDA ratio in recent years suggests a potential risk in cash flow coverage.

✅ Fundamental Strength & Profitability

Core profitability indicators such as return on assets and equity underscore Albemarle’s operational efficacy and profit margins' trajectory.

Year 2024 2023 2022
Return on Equity -11.84% 16.72% 33.70%
Return on Assets -7.10% 8.61% 17.40%
Margins: Net -21.93% 16.36% 36.75%
Margins: EBIT -29.72% 3.77% 34.92%
Margins: EBITDA -18.77% 8.24% 39.03%
Margins: Gross 1.16% 12.33% 42.00%
R&D to Revenue 1.61% 0.89% 0.98%

Profitability metrics illustrate volatility, yet show strong R&D investment commitment which can fuel future advances and market positioning.

📉 Price Development

Price Development Chart

✅ Dividend Scoring System

Criteria Score
Dividend yield 3
Dividend Stability 5
Dividend growth 2
Payout ratio 2
Financial stability 3
Dividend continuity 5
Cashflow Coverage 3
Balance Sheet Quality 3
Overall Score: 26/40

✅ Rating

Albemarle Corporation demonstrates strong dividend stability marked by an illustrious history of 32 consistent years. However, current fiscal metrics signal apprehension necessitating critical oversight. The enterprise's commitment to R&D and innovation posits long-term potential, yet prudence is advised amidst evident profit volatility. A hold recommendation is suitable under current forecasts, but prospective capital appreciations could prove opportunistic as operational efficiencies strengthen.